−0.396SEK
−11.49 MSEK
78.00 KSEK
21.01 M
About LIPIDOR AB
Sector
CEO
Ola Holmlund
Website
Headquarters
Solna
Founded
2009
ISIN
SE0012558617
FIGI
BBG00Q3QMWL3
Lipidor AB is a drug development company. It develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections and atopic dermatitis. Its products include pharma, consumer healthcare, and animal care. The company was founded by Nils Erik Anders Carlsson, Olle Holmertz, Jan Holmbäck, Gerhard Miksche, and Bengt Goran Herslöf in 2009 and is headquartered in Solna, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LIPI is 0.30 SEK — it has increased by 20.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange LIPIDOR AB stocks are traded under the ticker LIPI.
Yes, you can track LIPIDOR AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, LIPI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LIPIDOR AB stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LIPIDOR AB EBITDA is −14.93 M SEK, and current EBITDA margin is −19.14 K%. See more stats in LIPIDOR AB financial statements.